Shared vision on Biomarkers
Ambition and current status
Biomarker Bay, BBay, is a Biomarker service consortium offering one portal for the full range of Biomarker assays, biomarker
confirmation & assay development, assay validation, clinical validation and bioanalysis of biomarkers. BBay brings together academic expertise, biobanks and longstanding contract research to identify, develop and perform analysis for reliable & innovative biomarker and companion diagnostic assays.
Unique features BBay:
- Paring knowledge and expertise of academia and industry
- Fast-track analysis
- Development of biomarkers & companion diagnostics
- State of the art equipment, (pre)-clinical setting, CROs & biobanks
Members actively involved in this project:
More information about this project
Ymke van der Geld, Business developer manager,
T: (050) 361 0486
First building block for Biomarker Bay
Friday November 13th 2015, the Biomarker Bay, BBay, contract between UMCG and a five Northern Dutch clinical research organizations was signed. The Partnership of UMCG, RuG and the companies QPS, ABL, Syncom, IQ corporation and Brains online brings together academic expertise on biomarkers, biobanks and longstanding contract research to identify, develop and perform analysis for reliable & innovative biomarker and companion diagnostic assays.
Biomarkers are indicators with which the course of diseases or biological state can be measured. As e.g. glucose is a known biomarker measurement for diabetes. But there are many more biomarkers and there are always new found. By combining the knowledge from the companies and the UMCG we hope that BBay, Biomarker Bay, can attract new business.
With the signing of the contract the first building block for the BBay initiative has been laid down. In the upcoming months the rest of the building blocks will be compiled to create the BBay organization.